期刊文献+

罗格列酮增强胰岛素抵抗大鼠胰岛素敏感性作用 被引量:2

Effects of roglitazone on enhancing insulin sensitivity in three rat-models with insulin resistance
下载PDF
导出
摘要 目的:研究罗格列酮对多种胰岛素抵抗(insulin resistance,IR)大鼠模型的作用。方法:分别建立2型糖尿病(T2DM)伴IR、高脂血症-IR、地塞米松(DX)诱导IR大鼠3种动物模型,观察罗格列酮对病鼠给药后2h血糖(FBG)、口服葡萄糖耐量试验(OGTT)后2h血糖(2hBG)以及给药后2h空腹血清血糖(FSG)、总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白-胆固醇(HDL-C)、低密度脂蛋白-胆固醇(LDL-C)、丙二醛(MDA),肿瘤坏死因子-α(TNF-α),胰岛素(Fins)含量及胰岛素敏感指数(ISI),超氧化物歧化酶(SOD)活性等指标的影响。结果:罗格列酮显著降低病鼠FSG,TC,TG,LDL-C和Fins、TNF-α的浓度(P<0.05),显著提高HDL-C含量及ISI(P<0.05),增强胰岛素敏感性。加强SOD活性和降低MDA的含量(P<0.05),增强抗氧化能力。结论:罗格列酮能调整各动物模型所致的糖脂代谢障碍,纠正高脂血症及高胰岛素血症,拮抗病鼠IR,改善其胰岛素敏感性,增强抗氧化作用。 OBJECTIVE To investigate the effects of roglitazone on insulin resistant rats induced by three series of different factors. METHODS Three animal models including type Ⅱ diabetic rats with insulin resistance (T2DR-IR) and dexamethasone-induced insulin resistant rats (DX-IR) and high fat and sugar diet-fed rats with hyperlipemia-insulin resistance were established performed, the effects of roglitazone on serum contents of fasting blood glucose(FBG), 2-hours blood glucose(2hBG) after oral glucose tolerance test(OGTT), the serum concentrations of fasting blood glucose (FSG), low-density lipoprotein cholesterol(LDL-C), high-density lipoprotein cholesterol (HDL-C), malondialdehyde (MDA), total cholesterols (TC), triacylglycerol (TG), leptin, tumor necrosis factor-α(TNF-α), fasting insulin (Fins) and index of insulin sensitivity (ISI), and activities of superoxide dismutase (SOD) were observed. RESULTS After administration of roglitazone, 2hBG after OGTT was significantly lowered (P〈0. (15) ; the IGT improved; the level of TG, TC, LDL-C were decreased (P〈0. 05) ; the content of HDL-C was heightened (P〈0. 05); the excessive contents of FSG, TNF-α and Fins were readjust (P〈0. (15), and enhanced ISI (P〈0. 0) ;the activity of SOD potentiated and content of MDA regressed (P〈0. 05). CONCLUSION Roglitazone can readjust hyperinsulinemia, correct hyperlipemia and hyperinsulinemia, enhance insulin sensitivity, antagonizing IR, and intensify antioxidation.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2007年第1期33-36,共4页 Chinese Journal of Hospital Pharmacy
基金 广东省中医药管理局(编号:101040 302002) 广州市医药卫生科技项目(编号:2004107)
关键词 罗格列酮 2型糖尿病 高脂血症 地塞米松 大鼠 胰岛素抵抗 胰岛素敏感性 roglitazone type 2 diabetes mellitus hyperlipemia dexamethasone rat insulin resistance insulin sensitivity
  • 相关文献

参考文献8

二级参考文献51

共引文献94

同被引文献13

  • 1刘杰,刘遂心,沈玄霖.代谢综合征患者胰岛素抵抗与游离脂肪酸的变化及非诺贝特的干预[J].中国医学工程,2006,14(2):117-119. 被引量:4
  • 2陈景海,宋晓武,王怡淳,曾向村,王军,季晓君,赵汤艳,王小青.罗格列酮对原发性高血压伴胰岛素抵抗患者的降血压作用[J].中国临床药理学杂志,2007,23(3):227-229. 被引量:2
  • 3Douglas G. Johns, Zhaohui Ao, Marianne Eybye, et al. Rosiglitazone protects against ischemia/repeffusion-induced leukocyte adhesion in the zucker diabetic fatty rat[ J]. JPET,2005 ;315 ( 3 ) : 1020-7.
  • 4Chen L,Sai Ma,Wei LX,et al. Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart [ J ]. Heart vessel ,2007; 22:335-44.
  • 5Gao F, Yue TL, Shi DW,et al. p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation [J]. Cadiovasc Res, 2002 ; 53 : 414-22.
  • 6Walker M J, Curtis M J, Hearse D J, et al. The Lambeth Conventions guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion [ J]. Cardiovasc Res, 1988 ;22:447-55.
  • 7Abbott RD, Donnhue RP, Kannel WB,et al. The impact of diabetes on survival following myocardial infarction in men vswomen:the Framingham study[ J]. JAMA ,1988 ;260:3456-60.
  • 8Joosen AM, Bakker AH,Kersten S,et al. The PPARgamma ligand rosiglitazone influences triacylglycerol metabolism in non-obese males, without increasing the transcriptional activity of PPARgamma in the subcutaneous adipose tissue [ J]. Br J Nutr,2008 ;99 (3) :487-93.
  • 9沈飞海,葛文涛,潘竞锵,吕俊华.茵陈蒿提取物对胰岛素抵抗大鼠调脂降压作用及其机制研究[J].中药材,2007,30(12):1573-1576. 被引量:10
  • 10吕雄文,李俊,邹宇宏,金涌,程文明,章秋,黄艳,张骏艳.老鹰茶总黄酮降血糖作用的实验研究[J].中国中医药科技,2008,15(2):119-121. 被引量:42

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部